Albireo Pharma (ALBO) Financials

$44.15

$-0.10 (-0.23%)

As on 02-Mar-2023 16:00EDT

Market cap

$916 Mln

Revenue (TTM)

$57 Mln

P/E Ratio

--

P/B Ratio

4.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	57.39	40.58	8.31	9.64	12.74	0.00
Cost of Revenue	2.55	1.36	--	--	--	28.20
Gross Profit	54.84	39.22	8.31	9.64	12.74	0.00
Operating Expenses	177.76	162.71	119.23	70.75	50.63	28.24
Operating Profit (EBIT)	-122.91	-123.49	-96.27	-61.11	-37.89	-24.58
Other Income	-0.61	103.39	--	3.69	-3.36	0.34
Profit before Tax	-134.93	-34.03	-107.63	-62.72	-46.09	-24.20
Provision for Tax	-3.79	--	--	--	0.02	0.21
Profit after Tax (Net Income)	-131.15	-34.03	-107.63	-62.72	-46.11	-24.41
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-131.15	-34.03	-107.63	-62.72	-46.11	-24.41

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	100.07	175.61	181.23	93.16	122.64	65.25
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	183.33	81.10	79.09	52.98	50.00	0.04
Current Liabilities	37.82	45.35	25.28	18.92	12.83	7.93
Total Liabilities	359.04	302.05	285.61	165.07	185.47	73.22

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	82.39	33.12	23.74	23.27	17.82	18.21
Current Assets	238.84	268.93	261.87	141.80	167.65	55.01
Total Assets	359.04	302.05	285.61	165.07	185.47	73.22
Total Debt*	--	10.00	12.70	--	--	--
Net Current Assets	201.02	223.58	236.58	122.88	154.83	47.08

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-107.56	-101.03	-52.92	-26.80	-27.57
Cash Flow from Investing Activities	--	102.92	-0.08	-0.54	-0.05	4.31
Cash from Financing Activities	--	2.76	220.28	23.50	139.18	45.84
Net Cash Inflow / Outflow	--	-1.88	119.17	-29.96	112.33	23.30

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-6.70	-1.79	-6.73	-5.23	-3.84	-3.05
Cash EPS ($)	--	-1.78	-6.72	-5.22	-3.84	-3.05
Adjusted Book Value ($)	--	9.24	11.33	7.76	10.22	8.16
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.66	-6.31	-4.41	-2.23	-3.45
Free Cash Flow per Share ($)	--	-5.69	-6.32	-4.45	-2.24	-3.47

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-17.93	-74.98	-58.13	-49.08	-51.52
ROE (%)	-105.65	-19.07	-78.45	-58.13	-49.08	-53.25
ROA (%)	-38.09	-11.58	-47.77	-35.78	-35.65	-47.83
EBIT Margin (%)	-215.23	-49.53	-1,158.77	-595.90	-361.78	-2,420,200.00
Net Margin (%)	-230.98	-23.64	-1,295.53	-470.60	-491.75	-7,266.07
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	432.68	3.88	-0.14	-0.24	12,739.00	-1.00
EBIT Growth (%)	-311.67	79.12	-67.66	-24.58	-90.44	-80.09
Net Profit Growth (%)	-173.98	68.38	-71.62	-36.01	-88.87	-77.49
EPS Growth (%)	-129.83	0.73	-0.29	-0.36	-0.26	0.78
Book Value Growth (%)	-44.93	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-13.00	-5.58	-4.86	-6.38	-8.39
Price / Book Value	4.30	2.52	3.31	3.27	2.40	3.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.11	-10.31	-3.76	-3.02	-2.83	-6.27
Close Price ($)	19.36	23.29	37.51	25.42	24.53	25.60
High Price ($)	37.63	43.41	49.00	38.69	39.87	29.20
Low Price ($)	16.02	20.30	11.26	16.13	19.10	15.31
Market Cap ($ Cr)	915.89	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.06	0.07	--	--	--
Short term debt to equity ratio	--	--	0.02	--	--	--
Current Ratio	6.32	5.93	10.36	7.49	13.07	6.94
Quick Ratio	6.23	5.93	--	--	--	6.94
Interest Coverage	-10.83	-1.44	-8.47	-10.84	-9.53	-605.05

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	3.54	8.06	--	--	22.88	72,600.00
Asset Turnover	0.17	0.14	0.04	0.05	0.10	0.00
Receivable days	--	29.45	--	110.49	52.19	200,157.00
Inventory Days	--	52.26	--	--	--	--
Payable days	--	1,589.08	--	--	--	9.71
Cash Conversion Cycle	--	-1,507.37	--	--	--	200,147.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.